Survival and signals of response in advanced sarcoma patients enrolled on phase 1 trials in the era of precision oncology and novel immunotherapies.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.11063
Abstract: 11063 Background: Few effective US FDA approved therapies exist for refractory, metastatic sarcomas. Many of these patients therefore enroll onto phase 1 clinical trials. Because tumor-specific outcomes are not always reported in less common cancers… read more here.
Keywords: sarcoma; response; novel immunotherapies; sarcoma patients ... See more keywords
The role of novel immunotherapies in non-Hodgkin lymphoma.
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/tcr.2017.01.08
Abstract: Immunotherapy is an evolving modality in the treatment of non-Hodgkin lymphoma. Vaccinations with patient-specific tumor-derived antigens have been developed to strengthen immune response to tumor. The success of rituximab, a monoclonal antibody for CD20 on… read more here.
Keywords: lymphoma; immunotherapies non; hodgkin lymphoma; novel immunotherapies ... See more keywords
Novel Immunotherapies for Osteosarcoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.830546
Abstract: Osteosarcoma (OS) is the most common primary malignant bone sarcoma mainly affecting adolescents and young adults, which often progresses to pulmonary metastasis and leads to the death of OS patients. OS is characterized as a… read more here.
Keywords: metastasis; immunotherapies osteosarcoma; novel immunotherapies;
Novel Immunotherapies for Autoimmune Hepatitis
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2017.00008
Abstract: Autoimmune hepatitis (AIH) is a multifactorial autoimmune disease of unknown pathogenesis, characterized by a loss of immunological tolerance against liver autoantigens resulting in the progressive destruction of the hepatic parenchyma. Current treatments are based on… read more here.
Keywords: autoimmune hepatitis; hepatitis; novel immunotherapies; immunotherapies autoimmune ... See more keywords